Podcast appearances and mentions of Gene editing

In this episode Jeffrey speaks to an audience at the Real Truth About Health conference. He discusses concerns about gene editing in the biotech industry, using the example of gene-edited cows in Brazil. These cows were engineered to be hornless but ended up containing antibiotic-resistant genes due to the presence of bacterial DNA. This raises the risk of untreatable infections and highlights the potential for creating new diseases through gene editing. Jeffrey also mentions the lack of regulatory oversight for certain genetically engineered mushrooms using CRISPR technology and emphasizes the need for caution and thorough evaluation of the risks associated with gene editing. The Institute for Responsible Technology is working to protect you & the World from GMOs (and while we're at it, Roundup®...)  To find out exactly how we do this and to subscribe to our newsletter visit https://www.responsibletechnology.org/ Watch our short film, "7 Reasons Why Gene Editing is Dangerous and Unpredictable" Watch the film: Secret Ingredients Watch "Don't Let the Gene Out of the Bottle" Get the book: "Seeds of Deception" IG @irtnogmos Facebook @responsibletechnology YouTube @TheInstituteforResponsibleTechinology Twitter @TheInstituteforResponsibleTechnology

SPN Film Director for ‘Final Days', Matthew Skow joins Stew to discuss the successful launch of the newest Stew Peters original presentation. In this segment, they go into a deep dive of the Scientific Technological Elite and their plans to become gods. Karen Kingston's research was featured in the release of SPN Exclusive ‘Final Days' and she joins the Stew Peters Show to break down her explosive findings from the patents in the documentary. The DoD invested nearly half a billion dollars in synthetic biology, while Top U.S. Intelligence officials call Gene Editing a Weapon of Mass Destruction. American patriot, TX Attorney General Ken Paxton is being impeached because he's a threat to the RINOs in the Texas House! TX G.O.P. Chairman, Matt Rinaldi joins Stew to detail the witch hunt set up against the outspoken and courageous AG Paxton, in order to politically persecute him and remove him from office! The vaccine's deadlines isn't limited to just the vaccinated. Spike proteins may be able to jump hosts, and spread their clot-inducing health hazards to everyone! The Final Days may be approaching, but The Wellness Company is here to help with their all-natural, clot-killing supplements and products. Go to: FinalDaysProtocol.com and get the help you need to fight through the Final Days! Dr. Robert Seik from The Wellness Company joins Stew to detail the very real impacts of the vaccine and it's ability to shed from host to host. Watch this new show NOW at Stewpeters.com! Keep us FREE and ON THE AIR! SUPPORT THE SPONSORS Below! Protect your retirement, Visit our friends at Goldco! Call 855-706-GOLD or visit https://goldco.com/stew Get High Quality Prepper Food, NOW with $100 Buckets! Use Promocode STEW for Big Discounts at https://HeavensHarvest.com Taxation is THEFT! Never again voluntarily pay the Washington D.C. Swamp, legally and safely, GUARANTEED when you attend Freedom Law School! Visit: https://FreedomLawSchool.org Gun Holsters, BIG SALE! Just go to https://www.vnsh.com/stew and get $50 OFF! Clean up your AIR with these high quality air filtration systems, and protect yourself from shedding: https://thetriadaer.com/ Support anti-vax activism, free clinic care, and MANLY products like IGF1 visit:https://Vaccine-Police.com Check out https://nootopia.com/StewPeters for help increasing your mental & physical strength to battle the deep-state's KRYPTONITE plot against Americans! Magnesium is VITAL for sleep and stress, Get high quality magnesium and support the show with using Promocode STEWPETERS10: https://magbreakthrough.com/stewpeters High Quality CBD, Check out: https://kuribl.com/ Use Promocode STEW20 for 20% off your order or premium CBD! Protect yourself from Spike Proteins by getting the protocol: https://spikeprotocol.com Doctors appointments, with REAL Doctors that care, let them know Stew sent you at https://heroicdoctors.com Antarctic krill Oil is a lifesaver, FIX your swollen feet today at https://stopswollenfeet.com Go Ad-Free, Get Exclusive Content, Become a Premium user: https://www.stewpeters.com/subscribe/ Follow Stew on Gab: https://gab.com/RealStewPeters See all of Stew's content at https://StewPeters.com https://www.givesendgo.com/defendlauren

Dr. Jon Oatley, associate dean for research for the College of Veterinary Medicine and a professor at Washington State University discusses advances in gene-editing in livestock, a technique that alters an animal's genetic code to focus on desired traits. His team recently received U.S. Food and Drug Administration investigational authorization to create food for humans from gene-edited pigs in a process that is akin to traditional selective breeding. Gene-editing also could play an important role in meeting the growing global demand for protein over the next few decades.

Thanks for tuning in to RealAg on the Weekend! On this episode, host Shaun Haney is joined by Kody Blois, chair of standing committee on agriculture to discuss recommendations for supporting Canadian agriculture. As well as Carmen Prang, Saskatchewan Wheat to talk about seed testing and an update on the use of Lambda-cy products. We... Read More

Several government departments, consultations, and decisions are converging to clear a path for gene-editing technology to be approved as a breeding technique for conventional crops. That’s right, if the last hurdle can be cleared — approval of gene-edited plants for livestock feed — a variety or cultivar produced with gene-editing techniques would be considered non-novel... Read More

We've heard many stories on Raise the Line about patients and their family members who, upon getting a rare disease diagnosis, build a non-profit organization from scratch to boost advocacy and research for the condition in question. This is obviously a pretty big hill to climb for people with no background in such things. Well, today we're going to learn about Beacon for Rare Diseases, a UK non-profit designed to provide the expertise and support needed to get a rare disease patient group off the ground, and to connect these groups with each other for the purpose of mutual education and support. “What we've seen is that people forming and building patient organizations can help really trigger a new community around that, and help drive the field forward,” Beacon CEO Dr. Rick Thompson tells host Shiv Gaglani. “What we want to do as an organization is help those patient groups form, to grow, and to professionalize their work.” Tune in to find out how Dr. Thompson's background in evolutionary biology, research and education impacts his work at Beacon, why rare diseases should be approached in the same way as cancer, and his interest in repurposing existing drugs for use in treating rare diseases. Mentioned in this episode:  https://www.rarebeacon.org/ 

“It is my deepest wish for all of my students to find me as a mentor and a coach,” says Beth Hendricks, RN, MSN and assistant professor at New Mexico State University School of Nursing. That can be traced back in part to a nursing educator early in her career who took that approach and built her confidence. Being devoted to paying that forward is one reason Hendricks is the winner of the 2022 Osmosis Raise The Line Faculty Awards in the RN-Nurse Practitioner category. Her student nominators describe her as both empathetic and driven to see them succeed, which is a deliberate balance Hendricks tries to strike. “Having their backs but also challenging them is the best method for connecting with students,” she tells host Michael Carrese. Check out this insightful conversation on how to motivate students to fight through “imposter syndrome,” the importance of learning to think like a nurse, and why she encourages students to find their unique learning style among many other tips for educators. Mentioned in this episode: www.osmosis.org/faculty-awards

We've learned quite a bit on Raise the Line about at-home monitoring technology for chronic disease management, but on this episode we're going to explore the use of tech for a different aspect of the patient experience: post-surgical care. It's a significant issue because hospitals are incentivized to discharge patients as soon as possible, leaving many to recover at home with varying degrees of support. “The whole postoperative period is a huge black box of missing information. We really don't know how patients are doing after their surgery because we're not capturing the 24-7 experience the patient is living through,” says Dr. Sanjeev Suratwala, an orthopedic spine surgeon who co-founded Recuperet Health to fill that information gap. He tapped software engineer and management consultant Gary Arora to develop Recuperet's technology platform with the aim of keeping it simple for users. “You simply log in with your credentials. It's like watching Netflix on your browser. You don't need to download or install anything,” he tells host Michael Carrese. Patients wear Fitbits that track vital signs, and the system is designed to send alerts to providers -- and a patient-designated caretaker - if something seems concerning.  Tune in to learn how Recuperet is leveraging AI and gamification as part of its approach, and how this solution can be broadened to other specialties beyond orthopedics. Mentioned in this episode: https://recuperet.io 

“I noticed early on in my academic career that the traditional methods of engagement and the lecture was no longer working for millennials and Gen Z, which is the first generation to completely grow up being immersed in technology,” says Dr. Nicolene “Nikki” Lottering of Bond University in Queensland. That set the assistant professor of anatomy and forensic anthropologist on the path of determining how to use technology effectively without going too far. “For me, it's about the responsible use of technology to meet students halfway and harness that power to engage them and make them excited about what they're learning.” This thoughtful approach is one of the reasons Lottering is the winner of the 2022 Osmosis Raise the Line Faculty Award in the Anatomy and Physiology category. Another, according to her student nominators, is her compassion for her students. This became particularly pronounced during COVID which presented enormous challenges to educators and students alike. “I believe good education comes from a place of genuinely caring about your students,” she tells host Michael Carrese. “We can learn as a community and we can, through learning, find coping strategies as well. It's not always about the content, but it's actually about the community.” Don't miss this inspiring conversation from an educator with many insights on how to connect students to their learning and to each other. Mentioned in this episode: www.Osmosis.org/faculty-awards

Moral Enhancement, The Virtues, And Transhumanism Moving Beyond Gene Editing by Angelicum Thomistic Institute

Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.

Perhaps the most noteworthy element of Osmosis from Elsevier's Year of the Zebra educational initiative is the new, open-access, peer-reviewed journal Rare. Open Research in Rare Diseases.It joins Elsevier's leading collection of 2,500 publications in science and medicine. Rare is an open journal in multiple senses because, in an unusual step, contributions are being welcomed from patients as well as scientists. “We need the patient's voice to find out what their needs and challenges are every day,” says editor-in-chief, Dr. Wendy van Zelst-Stams. “We really want to have both a clinical impact on rare disease patients and an impact on their well-being in daily life.” Dr. van Zelst-Stams is taking on this new role in addition to her work leading the Clinical Genetics Section in the Department of Human Genetics of the Radboud University Medical Center and the Dutch Society of Clinical Genetics. In this enlightening conversation with host Shiv Gaglani, you'll learn about Europe's efforts to improve care for rare disease patients, the “DNA-first” approach her program takes to reduce the diagnostic odyssey, and the types of content that will be featured in this multidisciplinary scientific journal. Mentioned in this episode: https://www.sciencedirect.com/journal/rare

“Even my mother always told me that my biggest strength is my explanation capability,” says Dr. Kishore Banerjee, the winner of the 2022 Osmosis Raise the Line Faculty Awards in the Medicine - Osteopathy category. It's a skill the pathologist and educator has continued to hone over many years of teaching. “If you can create analogies and compare things with a real-life experience, then it becomes very easy for the student.” Better yet, Dr. Banerjee tells host Michael Carrese, is the prospect of enhancing the images he is trying to create for students using new technologies. “If we can create an immersive experience for students using the metaverse or artificial intelligence, that would be wonderful.” Throughout the podcast, Dr. Banerjee emphasizes the importance of making the learning process an enjoyable experience, one that students look forward to, which aligns him perfectly with the core Osmosis value of Spread Joy. “If the learning is happening in a fun environment, only then can you learn it properly.” By the end of this delightful conversation, you'll understand why Dr. Banerjee was selected as a winner out of the thousands of nominations Osmosis received from nearly 400 institutions worldwide. Mentioned in this episode: www.osmosis.org/faculty-awards

This week our guest is British biologist, Nessa Carey, who has researched and written extensively about the latest trends in molecular biology and biotechnology for several decades now. This includes her 2011 book, the Epigenetics Revolution, and her more recent 2019 book, Hacking the Code of Life.  In this episode, we lay some biological groundwork by first discussing the often misunderstood field of epigenetics, a process wherein our DNA changes how it's expressed throughout our lives. From there we dive deeply into gene editing and CRISPR, discussing the current state of the art, what's possible and what isn't, how to use gene editing to heal disease and address ecological issues, the existential threats gene editing poses for our species and planet, regulation, and much more.  Find out more about Nessa and her work at nessacarey.co.uk** Learn more about Singularity: ⁠⁠⁠su.org⁠⁠⁠ Host:⁠⁠⁠ Steven Parton⁠⁠⁠ - ⁠⁠⁠LinkedIn⁠⁠⁠ /⁠⁠⁠ Twitter⁠⁠⁠ Music by: Amine el Filali

Some of you may have a general idea about how Osmosis got started, but today you are going to get the full, fascinating story from one of its co-founders, Shiv Gaglani, who we welcome back to the Raise the Line podcast as our special guest. Shortly into his first year of medical school at Johns Hopkins in 2011, Shiv, and his co-founder Ryan Haynes, realized medical education was overdue for an upgrade. “The research was clear on how people learn and how to get them to engage in their education, but professors weren't being taught how to teach. We wanted to bring evidence-based education tools like spaced repetition, test-enhanced learning, memory palaces and flipped classrooms to medical education.” They also wanted to make it fun, efficient and personalized, keying off the customized recommendations media giants such as Netflix and Facebook were using. After completing their second year, both took a leave from med school to build Osmosis based on those insights. After growing it from a crowdsourced question bank for classmates into a global education platform serving millions of future healthcare professionals, Shiv shepherded the acquisition of the company by Elsevier in 2021, freeing him to return to Johns Hopkins to complete his degree which he recently moved to Baltimore to do. So, what's it like to go from running the company to being a student using the product he helped build? Tune in to this delightful episode to find out, to learn what specialties he's considering and for advice on using “negative” emotions to achieve productive outcomes.

Join us on this special episode of Raise the Line as we speak with Theodosia Adanu, Principal Librarian and Head at University of Ghana and winner of the 2022 Raise the Line Faculty Award in the Librarian category. When host Lindsey Smith asked Adanu which of the Osmosis values she resonated with most, her response was immediate. “When I think of the heart, I think of passion. I think for anyone to be able to make a difference, you ought to be passionate about things, and this is one thing I'm passionate about.”  According to her students, Adanu's unwavering drive to affect change and encourage them to succeed are just two of the reasons she was nominated and chosen for the award. In her conversation with Lindsey, Adanu describes the parts of the job she loves most, including helping students discover and learn new things.  She also touches on concerns about information literacy. “I do my best to make sure that everybody knows about it and is practicing the tenets of information literacy. That's a gap I'd like to see through.”Mentioned in this episode: www.osmosis.org/faculty-awards

One effective approach to teaching is to identify where students may have some weaknesses and then provide them with additional resources or information to shore up their understanding of that topic. Well, that's exactly what Elsevier's ClinicalKey Student Assessment is designed to do, and because it's an online platform, the process is efficient for both instructors and students. “It's a foundation to help students in that journey of self-discovery and self-learning which, hopefully, will set them up for the rest of their careers,” says Dr. Phil Xiu, the platform's editor-in-chief. Xiu's journey to that role includes many years of involvement in medical education and health tech, from writing textbooks to becoming the series editor of Elsevier's Crash Course book series which has sold over a million copies and been translated into eight different languages. In this enlightening conversation with host Michael Carrese you'll also learn about efforts to improve diversity, equity and inclusion in medical training, how blockchain technology is being used to enhance patient access to their complete medical record, and how being a practicing family physician shapes Xiu's work as an educator.

According to scientists, 30,000 species per year are being driven towards extinction and 50% of all species could be extinct by 2050 due to climate change. But what if there was something we could do, in addition to conservation, to change this trajectory? That's what the scientists and engineers at Colossal Biosciences are working towards: reversing extinction. Using CRISPR and advanced gene editing techniques, they plan to bring back the woolly mammoth and the dodo bird to help combat climate change and complement existing conservation efforts. Join us to discuss this topic with Ben Lamm (Colossal Biosciences); Tom Chi (At One Ventures); and John Calvelli (Wildlife Conservation Society).

CRISPR has emerged as a powerful tool for altering DNA sequences with incredible precision, opening up new avenues of research into the treatment of disease. In this episode, we explore the science behind CRISPR, as well as its potential. From curing genetic disorders to creating new crop varieties, the possibilities seem endless. Our four guests today are scientists working to push these gene editing tools to the next frontier.

David Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice-chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator. Liu's research integrates chemistry and evolution to illuminate biology and enable next-generation therapeutics. His major research interests include the engineering, evolution, and in vivo delivery of genome editing proteins such as base editors and prime editors to study and treat genetic diseases; the evolution of proteins with novel therapeutic potential using phage-assisted continuous evolution (PACE); and the discovery of bioactive synthetic small molecules and synthetic polymers using DNA-templated organic synthesis and DNA-encoded libraries. Base editing—the first general method to perform precision gene editing without double-stranded breaks, and a Science 2017 Breakthrough of the Year finalist—as well as prime editing, PACE, and DNA-templated synthesis are four examples of technologies pioneered in his laboratory. These technologies are used by thousands of labs around the world and have enabled the study and potential treatment of many genetic diseases. Four base editing clinical trials are already underway to treat leukemia, hypercholesterolemia, beta-thalassemia, and sickle-cell disease, with the first base editing clinical readout occuring last December, when it was announced that Alyssa, a 13-year-old girl in the UK, was cleared of T-cell leukemia by receiving triply base-edited CAR-T cells.Liu graduated first in his class at Harvard College in 1994. During his doctoral research at UC Berkeley, Liu initiated the first general effort to expand the genetic code in living cells. He earned his PhD in 1999 and became assistant professor of chemistry and chemical biology at Harvard University in the same year. He was promoted to associate professor in 2003 and to full professor in 2005.Liu became a Howard Hughes Medical Institute investigator in 2005 and joined the JASONs, academic science advisors to the U.S. government, in 2009. In 2016 he became a Core Institute Member and Vice-Chair of the Faculty at the Broad Institute of MIT and Harvard, and Director of the Chemical Biology and Therapeutics Science Program. Liu has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the American Association for the Advancement of Science. He is the 2022 King Faisal Prize Laureate in Medicine.He is the founder or co-founder of several biotechnology and therapeutics companies, including Prime Medicine, Beam Therapeutics, Editas Medicine, Pairwise Plants, Exo Therapeutics, Chroma Medicine, Resonance Medicine, and Nvelop Therapeutics.Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)

Jimmy Maxwell is a pianist and band leader based in New Orleans who has played a central role in organizing the music of Mardi Gras for decades. He is also a lover of myth and has recently become the audio archivist for the Joseph Campbell foundation. Jimmy's Reading List: The Emperor of all Maladies by Siddhartha Murkherjee The Gene by Siddhartha Murkherjee The Hero With a 1000 Faces by Joseph Campbell Thou Art That by Joseph Campbell The Inner Reaches of Outer Space by Joseph Campbell The Code Breaker: Jennifer Doudna, Gene Editing and the Future of the Human Race by Walter Isaacson If you enjoyed this conversation please leave a review in your podcast app. CancerTalks is a platform for anyone who has been touched by cancer. Write to us at info@cancertalks.com if you have a story to share. If you're moved to donate, please visit cancertalks.com/donate.  This podcast was produced by Claire de Laszlo with editing and original music by Annie Murnighan. Cheryl Buck is the vision and heart behind CancerTalks, Kaitlyn Stein makes this work financially sustainable, and Nora Rice helps spread the word through social media direction. As always, we want to extend a special thanks to our donors, friends, and volunteers. We couldn't do this without you!

This talk was given on October 5th, 2022 at Dartmouth College. For more information please visit thomisticinstitute.org. About the speaker: Fr. Nicanor Austriaco, O.P., completed his Bachelor's Degree (B.S.E.) in Bioengineering, summa cum laude, at the University of Pennsylvania, and then earned his Ph.D. in Biology from M.I.T. in the laboratory of Professor Leonard Guarente, where he was a fellow of the Howard Hughes Medical Institute (HHMI). He was ordained a priest in the Order of Preachers in May of 2004. He completed his Pontifical License in Sacred Theology (S.T.L.) in Moral Theology, summa cum laude, at the Dominican House of Studies in Washington, DC, in 2005, and a Pontifical Doctorate in Sacred Theology (S.T.D.), magna cum laude, at the University of Fribourg in Switzerland, in 2015. Fr. Austriaco currently serves as Professor of Biological Sciences & Professor of Sacred Theology at the University of Santo Tomas in Manila, Philippines. Before this position, he was Professor of Biology and of Theology at Providence College in Providence, Rhode Island. His NIH-funded laboratory at Providence College is investigating the genetics of programmed cell death using the yeasts, Saccharomyces cerevisiae and Candida albicans, as model organisms. Papers describing his research have been published in PLoS ONE, FEMS Yeast Research, Microbial Cell, Cell, the Journal of Cell Biology, and the Proceedings of the National Academy of Sciences USA, among others. In philosophy and theology, his essays have been published in the National Catholic Bioethics Quarterly, Theological Studies, Nova et Vetera, The Thomist, Science and Theology, and the Linacre Quarterly. His first book, Biomedicine and Beatitude: An Introduction to Catholic Bioethics, was published by the Catholic University of America Press in 2011. It was recognized as a 2012 Choice outstanding academic title by the Association of College and Research Libraries.

We look at a gene editing breakthrough, a new technique to correct genetic errors in sick patients. Roland speaks to Professor David Liu to learn about the base editing technology. Also, we look into the complex causes of last year's post-pandemic spike in child hepatitis. Professor Judy Breuer and her colleagues may have found an explanation behind the unexpected outbreak. And the James Webb Space Telescope continues to seek out the secrets of our universe. Professor Beth Biller and Dr Elsa Ducrot have the details on the atmospheres of two very distant, and very different, exoplanets. Plus, how to get sober – for mice. Professor Steven Kliewer explains how certain mammals have evolved to deal with the intoxicating effects of ethanol. Producer: Roland Pease Assistant Producer: Sophie Ormiston (Image: Genetic engineering 3D rendered conceptual image. Credit: Getty Images)

Ever since the discovery of DNA scientists have been on a quest to understand the secrets of the human genome. This quest has not only involved analysing the role genes play in making us who we are – the history of genetics has also been shaped by a desire to explore how far our genes can be altered or enhanced.  In 2012, the discovery that a molecule known as CRISPR could be programmed to add and remove elements of DNA marked a huge leap forward, transforming research into treatments for diseases as varied as cancer, Alzheimer's, sickle cell and HIV, as well as many rare genetic conditions.  In this conversation, recorded at the Francis Crick Institute in London, our panel explores the urgent ethical questions that these advances have unleashed. Chaired by Dr Guddi Singh, the panel featured Tom Whipple, Science Editor at The Times, Shani Dhanda, an award-winning disability activist and inclusion specialist, Dr Güneş Taylor, postdoctoral research scientist at the Francis Crick Institute, and Jimi Olaghere, one of the first people in the world to take part in a life-changing clinical trial using gene therapy to treat sickle cell disease.  In this episode (Part II) the panel responds to questions from the audience on the real life implications of gene editing, and the role society should play in regulating the field. If you missed part one of this conversation, please go back and listen now. The event was organised to coincide with a free exhibition at the Francis Crick Institute, London called ‘Cut and Paste,' exploring the future and ethics of gene editing. The exhibition runs until December 2023. Visit https://www.crick.ac.uk/CutandPaste to find out more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Ever since the discovery of DNA scientists have been on a quest to understand the secrets of the human genome. This quest has not only involved analysing the role genes play in making us who we are – the history of genetics has also been shaped by a desire to explore how far our genes can be altered or enhanced.  In 2012, the discovery that a tool known as CRISPR could be programmed to add and remove elements of DNA marked a huge leap forward, transforming research into treatments for diseases as varied as cancer, Alzheimer's, sickle cell and HIV, as well as many rare genetic conditions.  In this conversation, recorded at the Francis Crick Institute in London, our panel explores the urgent ethical questions that these advances have unleashed. Chaired by Dr Guddi Singh, the panel featured Tom Whipple, Science Editor at The Times, Shani Dhanda, an award-winning disability activist and inclusion specialist, Dr Güneş Taylor, postdoctoral research scientist at the Francis Crick Institute, and Jimi Olaghere, one of the first people in the world to take part in a life-changing clinical trial using gene therapy to treat sickle cell disease.  In this episode (Part I) the panel explores questions such as: what diseases should we try to cure? How should these be prioritised? What assumptions shape perceptions of disability? Where does the line between editing and enhancing fall? And ultimately who gets to decide?  The event was organised to coincide with a free exhibition at the Francis Crick Institute, London called ‘Cut + Paste,' exploring the future and ethics of gene editing. The exhibition runs until December 2023. Visit www.crick.ac.uk/CutandPaste to find out more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Bloomberg News Macro Strategist Cam Crise joins the program to break down how traders are pricing in the Fed's rate moves this week and outlook for markets amid bank uncertainty. Jenny Surane, finance reporter with Bloomberg News, joins the program to discuss Hindenburg short selling Block and crushing a portion of Jack Dorsey's wealth, as well as Hindenburg's recent involvement with Adani Group. Scott Harrison, Portfolio Manager at Argent Capital Management, joins the program to talk about sectors he likes and outlook for equities. Rania Sedhom, Managing Partner of the Sedhom Group, joins the program to discuss her recent commentary on how the SVB breakdown affects the legal hurdles of acquiring funding. Sanjiv Sanyal, economist, author, and principal economic advisor to the Indian government and prime minister Narendra Modi, joins the discuss India's growth potential, geopolitical balancing between China, Russia, and the US, and global economic and political uncertainty. Ali Urman, Genomics Analyst at ARK Invest (Fund: ARK Genomic Revolution ETF – ARKG), joins the program to talk about ETF investing in immunotherapy, gene editing, and the convergence of AI and tech in the health space. Hosted by Paul Sweeney and Jennifer Ryan.See omnystudio.com/listener for privacy information.

KSQD 3-22-2023: LPA, an atypical risk factor for heart disease; Questions about drug and food interactions with the green tea extract EGCG; A reaction to nebulized tea tree oil -- don't do this! CRISPR is 10 years old; Single nucleotide editing cures SCID